Ishii T - Search Results

1

Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.

Shi J, Zhao Y, Ishii T, Hu W, Sozer S, Zhang W, Bruno E, Lindgren V, Xu M, Hoffman R. Shi J, et al. Among authors: ishii t. Cancer Res. 2007 Jul 1;67(13):6417-24. doi: 10.1158/0008-5472.CAN-07-0572. Cancer Res. 2007. PMID: 17616702

2

Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis.

Ciurea SO, Merchant D, Mahmud N, Ishii T, Zhao Y, Hu W, Bruno E, Barosi G, Xu M, Hoffman R. Ciurea SO, et al. Among authors: ishii t. Blood. 2007 Aug 1;110(3):986-93. doi: 10.1182/blood-2006-12-064626. Epub 2007 May 1. Blood. 2007. PMID: 17473062 Free PMC article. Clinical Trial.

3

Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice.

Ishii T, Zhao Y, Sozer S, Shi J, Zhang W, Hoffman R, Xu M. Ishii T, et al. Exp Hematol. 2007 Nov;35(11):1633-40. doi: 10.1016/j.exphem.2007.07.005. Epub 2007 Aug 30. Exp Hematol. 2007. PMID: 17764815 Free article.

4

Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.

Wang X, Zhang W, Ishii T, Sozer S, Wang J, Xu M, Hoffman R. Wang X, et al. Among authors: ishii t. Cancer Res. 2009 Oct 1;69(19):7612-8. doi: 10.1158/0008-5472.CAN-09-1823. Epub 2009 Sep 14. Cancer Res. 2009. PMID: 19752087 Free PMC article.

5

Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera.

Ishii T, Bruno E, Hoffman R, Xu M. Ishii T, et al. Blood. 2006 Nov 1;108(9):3128-34. doi: 10.1182/blood-2006-04-017392. Epub 2006 Jun 6. Blood. 2006. PMID: 16757685 Free article.

6

Haematopoietic cell lineage distribution of MPLW515L/K mutations in patients with idiopathic myelofibrosis.

Hu WY, Zhao Y, Ishii T, Sozer S, Shi J, Zhang W, Bruno E, Hoffman R, Xu M. Hu WY, et al. Among authors: ishii t. Br J Haematol. 2007 May;137(4):378-9. doi: 10.1111/j.1365-2141.2007.06572.x. Epub 2007 Apr 4. Br J Haematol. 2007. PMID: 17408398 Free article. No abstract available.

7

Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders.

Ishii T, Wang J, Zhang W, Mascarenhas J, Hoffman R, Dai Y, Wisch N, Xu M. Ishii T, et al. Blood. 2009 Jun 4;113(23):5942-50. doi: 10.1182/blood-2008-09-179416. Epub 2009 Feb 4. Blood. 2009. PMID: 19196660 Free article.

8

Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo.

Sozer S, Ishii T, Fiel MI, Wang J, Wang X, Zhang W, Godbold J, Xu M, Hoffman R. Sozer S, et al. Among authors: ishii t. Blood Cells Mol Dis. 2009 Nov-Dec;43(3):304-12. doi: 10.1016/j.bcmd.2009.08.005. Epub 2009 Sep 16. Blood Cells Mol Dis. 2009. PMID: 19762257

9

Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders.

Sozer S, Wang X, Zhang W, Fiel MI, Ishii T, Wang J, Wisch N, Xu M, Hoffman R. Sozer S, et al. Among authors: ishii t. Blood Cells Mol Dis. 2008 Nov-Dec;41(3):284-91. doi: 10.1016/j.bcmd.2008.06.008. Epub 2008 Aug 19. Blood Cells Mol Dis. 2008. PMID: 18715806

10

Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.

Ishii T, Xu M, Zhao Y, Hu WY, Ciurea S, Bruno E, Hoffman R. Ishii T, et al. Leukemia. 2007 Feb;21(2):373-4. doi: 10.1038/sj.leu.2404475. Epub 2006 Nov 23. Leukemia. 2007. PMID: 17122864 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,485 results

Search Page

Filters